Iben S. Darfelt

Herning, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Preferences for Blood Glucose Management in Adult Intensive Care Unit Patients-An International Survey.

Preferences for Blood Glucose Management in Adult Intensive Care Unit Patients-An International Survey.

Journal: Acta anaesthesiologica Scandinavica

Published: December 12, 2025

"End-of-Life Care Is as Important as Any Other Lifesaving Task": A Scandinavian Survey Study.

"End-of-Life Care Is as Important as Any Other Lifesaving Task": A Scandinavian Survey Study.

Journal: Acta anaesthesiologica Scandinavica

Published: June 10, 2025

Response-Letter to the Editor: Consensus Statements on End-Of-Life Care in ICU.

Response-Letter to the Editor: Consensus Statements on End-Of-Life Care in ICU.

Journal: Acta anaesthesiologica Scandinavica

Published: June 04, 2025

Consensus statements on end-of-life care in ICU - A Scandinavian multidisciplinary Delphi study.

Consensus statements on end-of-life care in ICU - A Scandinavian multidisciplinary Delphi study.

Journal: Acta anaesthesiologica Scandinavica

Published: December 02, 2024

A window of opportunity for ICU end-of-life care-A retrospective multicenter cohort study.

A window of opportunity for ICU end-of-life care-A retrospective multicenter cohort study.

Journal: Acta anaesthesiologica Scandinavica

Published: April 05, 2024

Thromboembolic and bleeding events in ICU patients with COVID-19: A nationwide, observational study.

Thromboembolic and bleeding events in ICU patients with COVID-19: A nationwide, observational study.

Journal: Acta anaesthesiologica Scandinavica

Published: August 13, 2022

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.

Journal: Intensive care medicine

Published: February 07, 2022

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.

Journal: JAMA

Published: October 21, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026